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1. Introduction
Social Anxiety Disorder (SAD) is the most common anxiety
disorder, which is characterized by persistent fear and avoidance of
social situations (Stein and Stein, 2008;Mannuzza et al., 1995). The
causes and pathogenesis of SAD are not well elucidated. Besides
inheritable traits, several studies reported that childhood abuse
(CA), and particular emotional abuse, is an important risk factor for
the development of SAD (Gibb et al., 2007; Heim and Nemeroff,
2001).
Research in animals found that chronic exposure to early
adverse events, such as maternal deprivation, may have a lasting
impact on the neurobiology of the stress response, particularly on
the stress-regulating hypothalamic–pituitary–adrenal (HPA) axis
(see Heim and Nemeroff, 2001; Kaufman et al., 2000; Sanchez,
2006, for reviews). Epigenetic regulation of hippocampal gluco-
corticoid receptor expression may mediate the effects of early life
experiences on adult behavior (Weaver et al., 2004, 2007;
McGowan et al., 2009). Despite the importance for our under-
standing of how childhood abuse might lead to psychopathology,
only a few studies investigated the impact of early adverse
experiences on HPA reactivity (Heim et al., 2000; Bremner et al.,
2003; Elzinga et al., 2003). Consistent with the animal studies,
these studies found that CA is associated with increased HPA-axis
sensitivity to stress in womenwithMDD (Heim et al., 2000), and to
a smaller extent in Post-traumatic Stress Disorder (PTSD) (Bremner
et al., 2003; Elzinga et al., 2003). In healthy subjects, in contrast, CA
has been related to hypo-responsiveness of the HPA-axis to
psychosocial stress (Elzinga et al., 2008; Carpenter et al., 2007). An
important question that needs to be elucidated is whether HPA-
axis sensitization is speciﬁc for MDD (and PTSD), or whether it is a
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Background: Studies on depression have found that childhood abuse (CA) is associated with a persistent
sensitization of the hypothalamic–pituitary–adrenal (HPA)-axis to stress in adulthood. So far, it is
unknownwhether this HPA-axis sensitization is speciﬁc to depression, or whether this is a more general
outcome associated with CA in patients with mood and anxiety disorders. The aim of this study was to
investigate whether CA is associated with enhanced cortisol reactivity to psychosocial stress in Social
Anxiety Disorder (SAD).
Methods: Salivary cortisol levels before, during, and after exposure to psychosocial stress (i.e., Trier
Social Stress Task, TSST) in SAD patients with a history of childhood abuse (SAD + CA, n = 9) were
compared to cortisol levels in SAD patients without a history of childhood abuse (SAD  CA, n = 9),
patients with PTSD related to childhood abuse (n = 16), and healthy controls without a history of
childhood abuse (n = 16).
Results: Analyses showed that the SAD + CA group had a strongly increased cortisol reactivity (mean
peak: 17.5  1.9 nmol/l) compared to SAD  CA (mean peak: 9.0  1.1 nmol/l), PTSD (mean peak:
9.0  1.1 nmol/l) and healthy controls (mean peak: 9.6  1.4 nmol/l), whereas baseline cortisol levels did
not differ. The enhanced increase in the SAD + CA group was not explained by stronger anxiety in response to
the TSST.
Conclusions: Consistent with the ﬁndings in depression, these results show for the ﬁrst time that
childhood abuse is also associated with strongly increased cortisol reactivity in SAD. When replicated in
a larger sample, these ﬁndings may have important implications for the treatment of SAD.
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more general outcome of CA in patients with mood or anxiety
disorders, including patients with SAD.
So far, a number of studies investigated cortisol reactivity to
psychosocial stress in SAD, with mixed results (Condren et al.,
2002; Furlan et al., 2001; Levin et al., 1993; Martel et al., 1999).
Recently, we reported increased cortisol responses to the Trier
Social Stress Test (TSST) in SAD compared to PTSD and healthy
controls (Roelofs et al., 2009). This was in line with one other study
reporting increased cortisol responses to psychological stress in
SAD (Condren et al., 2002), but other investigations failed to ﬁnd
group differences (Furlan et al., 2001; Levin et al., 1993; Martel
et al., 1999). Besides several methodological differences, CA might
play an important role in these (inconsistent) ﬁndings, as none of
these studies included information about the presence of CA.
The aim of the present retrospective study is to investigate HPA
reactivity to a psychosocial stressor (TSST) in patientswith SADwho
report a history of (emotional, physical, or sexual) CA vs patients
with SADwho do not report experiences of abuse during childhood.
To investigate the speciﬁcity of the relation between abuse and HPA
reactivity in SAD, we also included patients with PTSD related to CA
and healthy participants without a history of CA.
2. Methods
2.1. Participants
Demographic variables and other characteristics of the groups are presented in
Table 1. Participants described here were part of a larger study (see Roelofs et al.,
2009). Patients with generalized SAD and PTSDwere diagnosedwith the Structured
Clinical Interview for DSM-IV Axis-I Disorders, SCID-i/p (First et al., 1996). Healthy
control (HC) participants were recruited via advertisements in local newspapers.
Exclusion criteria were: age <18 or >65 years, left handedness, psychotic disorder,
use of neuroleptics, substance use/addiction, chronic disease, use of corticosteroids
max 6 months before participation, and pregnancy or breast feeding.
The SAD group with a history of childhood abuse (SAD + CA) consisted of SAD
patients who reported emotional, physical or sexual abuse involving the primary
caretaker, which took place before the age of 16 (as assessed with the TEC).
Similarly, for the PTSD group, participants were only included when posttraumatic
stress symptoms were related to adverse events experienced before the age of 16
(excluding n = 3 patients from our original sample with PTSD associated with
trauma that occurred after age 16). From the HCs, participants who reported
emotional, physical or sexual abuse that had taken place before the age of 16
(excluding n = 6 healthy controls from the original sample) were excluded. These
inclusion and exclusion criteria resulted in the following groups: SAD + CA, n = 9;
SAD  CA, n = 9; PTSD, n = 16; HC, n = 16.
All participants were instructed to minimize physical exercise during the hour
preceding the experiment and not to take large meals, coffee, drinks with low pH or
cigarettes, because these variables can affect cortisol levels. The study was
approved by the local ethics committee and all participants provided written
informed consent.
2.2. Materials
2.2.1. The Trier Social Stress Test
The psychological challenge test consisted of a free speech (5 min) and a mental
arithmetic task (5 min), performed in front of an audience of three individuals,
which was preceded by an anticipation phase (5 min) in which participants
prepared the speech. During the speech, participants took on the role of a job-
applicant (job-deﬁnition is predeﬁned, based on what is challenging and relevant
for the participant). In case participants reported being unable to proceed with the
free speech they received a modiﬁed version of the TSST with up to three measures
helping participants to fulﬁll the task, without dropping out. The measures were in
ﬁxed order, and the next step was applied only if necessary: (1) giving verbal
encouragements during the free speech; (2) structured interview in stead of free
speech, involving direct questions about job application; (3) preterm cancellation of
free speech, and immediate continuation with the mental arithmetic task.
Table 1
Demographic variables and group characteristics.
Variable SAD+CA (n=9) SADCA (n=9) PTSD (n=16) HC (n=16) F-value p-value
Gender (M/F) 4M/5F 4M/5F 4M/12F 5M/11F 0.98(x2) 0.61
Age 32.9 (9.5) 27.8 (6.3) 35.1 (11.3) 39.3 (17.6) 1.61 0.20
Axis-I comorbiditya 6 5 14 0 19.38(x2) 0.000
GAD 1 1 3 0
Panic disorder 0 0 4 0
Obsessive comp. dis. 0 1 1 0
MDD 4 3 5 0
Dysthymic disorder 1 0 1 0
Medicationb 3N/6Y 4N/5Y 3N/13Y 11N/5Y 8.38(x2) 0.04
AD 3 3 2 0
Sedativesc 2 2 3 0
Otherd 1 0 3 2
Oral contraceptives 2 2 7 4
Social anxiety (SPAI) 166.8 (20.6)ad 152.0 (29.2)b 137.5 (32.3)cd 92.3 (34.3)abc 14.11 0.000
Depression (BDI) 22.4 (10.5)a 12.6 (15.1)b 17.1 (13.4)c 3.1 (2.1)abc 7.45 0.000
Childhood abuse (TEC) 4.3 (1.9)a 1.8 (1.3)be 8.6 (6.2)abc 2.3 (2.1)ce 9.22 0.000
Emotional 3.9 (n=8) 0.9 (n=3) 4.9 (n=12) 0.1 (n=1) 8.74 0.000
Physical 0.8 (n=3) 0.0 (n=0) 2.2 (n=8) 0.1 (n=1) 6.12 0.001
Sexual 0.7 (n=2) 0.0 (n=0) 4.6 (n=12) 0.1 (n=1) 9.89 0.000
Age
Emotional 7.6 years (1–15) n.a. 6.5 years (1–14) n.a.
Physical 5.5 years (1–12) n.a. 5.1 years (1–12) n.a.
Sexual 7.0 years (4–10) n.a. 7.1 years (1–11) n.a.
Duration
Emotional 10 years (2–18) n.a. 13.4 years (1–29) n.a.
Physical 8.5 years (6–12) n.a. 11.0 years (2–24) n.a.
Sexual 3.0 years (3) n.a. 6.6 years (1–16) n.a.
Impact
Emotional 3.9 (3–5) n.a. 3.8 (2–5) n.a.
Physical 2.5 (2–3) n.a. 3.8 (2–5) n.a.
Sexual 2.5 (2–3) n.a. 4.3 (2–5) n.a.
n: number of participants.
Data from questionnaires are presented in mean score and SD.
Cells with similar letters differ signiﬁcantly from each other (p<0.05).
a Assessed using the SCID.
b Total numbers do not correspond with the sum of the four subtypes because of overlap (patients may use more than one type of medication).
c Participants refrained from taking the medication min. 24h before the experiment.
d Including medication for respiratory tracts and blood pressure control.
e In the case of SADCA and HC, this only refers to events after 16 years.
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2.2.2. Cortisol, blood pressure, and subjective anxiety
Salivary cortisol, blood pressure, and subjective anxietymeasures were obtained
at 10 assessment points over a 130-min period, at 65, 35, 25, 10, 0, +15, +25,
+40, +50 and +65 min with reference to the start of the stressor (see Figs. 1 and 2).
All assessments were performed between 1 PM and 4 PM. To assess free cortisol
levels, saliva samples were obtained using Salivette collection devices (Sarstedt,
Rommelsdorf, Germany). The samples were stored at 20 8C before assaying.
Biochemical analysis of free cortisol in saliva was performed using a competitive
electrochemiluminescence immunoassay (ECLIA, Elecsys 2010, Roche Diagnostics),
as described elsewhere (Van Aken et al., 2003).
Blood pressure was measured from the non-dominant arm using an automatic
blood pressure monitor (Omron R5-I) that could be initiated manually.
Subjective anxietywasmeasured using a visual analogue scale (ranging from0 to
10) at each assessment point.
2.2.3. Questionnaires
Traumatic Experiences Checklist (TEC, Nijenhuis et al., 2002).
The TEC is a reliable and valid self-report inventory that assesses emotional
abuse and neglect, physical abuse, sexual harassment, and sexual abuse, as well as
general traumatic events, including loss of signiﬁcant others, life threat by disease,
parental divorce, and psychopathology of parents (i.e., alcohol or drug abuse). The
TEC version that was used in the present study contains 26 items, with the total
score ranging from 0 to 26. Besides the total score, there are scores for the presence
of emotional abuse (emotional neglect and emotional abuse in various settings, six
items), physical abuse (physical abuse in various settings, intentional threat to life,
and intense pain, ﬁve items), and sexual abuse (sexual harassment and sexual abuse
in various settings, six items). For each item it was assessed whether the event
happened yes or no, at which age the event ﬁrst took place, at which age the event
ended, and the impact of the event on a scale from 1 (not at all) to 5 (verymuch). All
items are preceded by the phrase: ‘‘Did this happen to you?’’ An example of
emotional abuse is: ‘‘Emotional abuse (e.g., being belittled, teased, called names,
threatened verbally, or unjustly punished) by your parents, brothers or sisters’’.
Cronbach’s a for the TEC total score is 0.86. Cronbach’s a for emotional abuse is
0.78, for sexual abuse 0.65, and for physical abuse 0.77. Test–retest reliability of the
TEC total score is r = 0.91. The test–retest for the speciﬁc types of abuse: emotional
abuse, r = 0.80; physical abuse, r = 0.86; sexual abuse, r = 0.88 (all p < 0.0001).
Concurrent validity as measured by the correlation between the TEC and the
Stressful Life Events Screening Questionnaire (SLESQ) total score (Goodman et al.,
1998) is strong, r = 0.77, p < 0.0001).
To measure social anxiety, the social anxiety subscale of the Social Phobia and
Anxiety Inventory (SPAI: Turner et al., 1989; Bo¨gels and Reith, 1999) was used and
depression severitywasmeasuredwith the Beck Depression Inventory (BDI-II: Beck
et al., 1961; van der Does, 2002).
2.3. Procedure
On the test day, participants arrived at the laboratory at 1.00 PM. After the ﬁrst
series of physiological and subjective assessments, subjects were adjusted to the
experimental environment using a relaxing movie, followed by a battery of
cognitive tests, of which the results are reported elsewhere (Roelofs et al., 2009).
After 65 min, the TSST was administered. Immediately after the TSST, the
experimenter came back and administered the cognitive tests again in the
presence of the audience (until +25 min with reference to onset TSST).
Subsequently, the audience left the room and returned for a debrieﬁng after the
last physiological assessment had taken place. One week after the experiment
patients were contacted for a second debrieﬁng (for more details, see Roelofs et al.,
2009).
2.4. Statistical analyses
To compare the four groups on cortisol reactivity to the TSST, analyses of
variance (ANOVA) for repeated measures were conducted with Group (SAD + CA vs
SAD  CA vs PTSD vs HC) as between-subjects factor and Time (10 assessment
points) as within-subjects factor, which was followed by univariate ANOVAs to
clarify the signiﬁcant effects. To control for the use of medication, gender
differences, and modiﬁcations in TSST administration (see Roelofs et al., 2009),
these factors were added as covariates in additional analyses. To investigate the
speciﬁcity of the effects on cortisol reactivity, similar repeated measures ANOVAs
were conducted for systolic and diastolic blood pressure and subjective anxiety. All
statistical analyses described employed a two-tailed a of 0.05, and effect sizes of
signiﬁcant results are reported to be using the Partial Eta Squared (h2). When
sphericity could not be assumed, within-subject effects were corrected using the
Greenhouse–Geisser procedure. Analyses were performed using SPSS 16.0.
3. Results
3.1. Cortisol reactivity
In the repeated measures ANOVA a main effect of Time was
found, due to a signiﬁcant increase in cortisol levels after the TSST
(F(9,414) = 10.98, p < 0.0001, h2 = 0.19). Also amain effect of Group
was found (F(3,46) = 4.03, p < 0.05, h2 = 0.21), which was speciﬁed
by a signiﬁcant Group Time interaction (F(27,414) = 2.62,
p< 0.05, h2 = 0.15) (see Fig. 1). Follow-up univariate ANOVA
analyses at the separate time points showed that this was due to
the fact that SAD + CA patients had higher cortisol levels compared
to the other three groups after stress induction (at +25 min
(F(3,49) = 3.51, p< 0.05); +40 min (F(3,49) = 5.35, p < 0.005);
+50 min (F(3,49) = 5.21, p< 0.005), and +65 min (F(3,49) = 4.46,
p< 0.01)), but not at baseline (from65 to +0 min, all ps>0.2), nor
immediately after the TSST (at +15 min: p = 0.17). At all time points
from +25 to +60 min the SAD + CA group had signiﬁcantly higher
cortisol levels than the SAD  CA, PTSD andHC group (all ps<0.01),
whereas the SAD  CA, PTSD and HC did not differ (all ps >0.5).
When controlling for Gender, Medication and TSST-modiﬁca-
tions as covariates, the main effect of Group (F(3,43) = 5.27,
p < 0.005, h2 = 0.27) and the Group  Time interaction
Fig. 1. Cortisol responses before, during and after stress exposure using the TSST.
Patients with SAD and a history of childhood abuse (SAD + CA) have signiﬁcantly
larger cortisol responses to the TSST than SAD patients without a history of
childhood abuse (SAD  CA), and control group patients with PTSD and healthy
subjects. **p < 0.01.
Fig. 2.Measures of subjective anxiety before, during and after stress exposure using
the TSST.
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(F(27,387) = 2.37, p < 0.05, h2 = 0.14) remained signiﬁcant. The
TSST-modiﬁcation was a signiﬁcant covariate which had a main
effect (F(1,43) = 7.38, p < 0.01, h2 = 0.15), indicating that partici-
pants with modiﬁed (i.e., milder) versions of the TSST had lower
cortisol levels (see also Roelofs et al., 2009). Gender did not show a
main effect, but interacted with time (F(9,387) = 3.36, p < 0.05,
h2 = 0.07), due to larger cortisol increases after the TSST in men
than in women. Use of medication was not a signiﬁcant covariate
(F(1,43) = 1.85, n.s.).
Finally, to control for depression rates, the individual BDI-II
total-scores were entered as an additional covariate into the
model. This did not affect the ﬁndings either: main effect of Group
(F(3,42) = 5.79, p < 0.005, h2 = 0.29) and Group  Time effect
(F(27,378) = 2.31, p < 0.05, h2 = 0.14). Moreover, depression was
not a signiﬁcant covariate (F(1,42) = 1.89, n.s.), nor did depression
interact with Time (F(9,387) = 0.43, n.s.). The same was true when
controlling for social anxiety severity as measured with the SPAI
(main effect of Group (F(3,42) = 3.77, p < 0.05, h2 = 0.21) and
Group  Time effect (F(27,378) = 2.41, p < 0.05, h2 = 0.15)). Social
anxiety was not a signiﬁcant covariate (F(1,42) = 0.05, n.s.), nor did
it interact with Time (F(9,387) = 1.72, n.s.).
4. Blood pressure
The repeated measures ANOVA on blood pressure showed a
signiﬁcant increase in both systolic blood pressure (main effect of
Time: F(9,405) = 11.63, p < 0.0001, h2 = 0.21) and diastolic blood
pressure (F(9,405) = 10.56, p < 0.0001, h2 = 0.19) in response to the
TSST, but no interaction with group (systolic blood pressure:
F(27,405) = 1.24, n.s.; diastolic blood pressure: F(27,405) = 1.31,
n.s.) nor a main effect of group (systolic blood pressure:
F(3,45) = 0.50, n.s.; diastolic blood pressure: F(3,45) = 1.15, n.s.).
5. Subjective anxiety
The repeatedmeasures ANOVA on subjective anxiety revealed a
signiﬁcant increase in anxiety after the TSST (main effect of Time:
F(9,414) = 26.80, p < 0.0001, h2 = 0.37). Independent of time,
higher anxiety levels were reported by all three patient groups
compared to controls (main effect of Group: F(3,46) = 8.26,
p < 0.0001, h2 = 0.35). A signiﬁcant Group  Time interaction also
emerged (F(27,414) = 2.10, p < 0.05, h2 = 0.12, see Fig. 2). Follow-
up univariate ANOVA analyses at the separate time points showed
signiﬁcant group differences at all time points (all ps<0.05) except
at +65 min (p = 0.10). At the ﬁrst time point (65 min) the
SAD + CA, SAD  CA and the PTSD group had signiﬁcantly higher
anxiety ratings compared to the HC group (p < 0.05), whereas the
patient groups did not differ. At time point35,25 and10 min,
PTSD patients and SAD  CA had signiﬁcantly higher anxiety
ratings compared to the HC group (all ps <0.05), whereas the
SAD + CA did not signiﬁcantly differ from the HC group.
Immediately before the TSST until +50 min after the TSST, all
three patient groups reported higher anxiety ratings than the HC
group (all p < 0.05). In addition, immediately after the TSST (at
+15 min), SAD + CA had lower anxiety ratings compared to the
SAD  CA group (p < 0.05).
6. Discussion
We found that a history of CA was associated with greatly
enhanced cortisol reactivity to a psychosocial stress task in
patients with SAD compared to patients with SAD who did not
report childhood abuse, and compared to patients with PTSD
related to CA and healthy controls without a history of CA. No
differences in baseline cortisol levels were found. Interestingly, the
increased cortisol response in the SAD + CA group was not
associated with enhanced blood pressure, nor with enhanced
subjective anxiety. In contrast, anxiety ratings in the SAD + CA
group were even lower immediately after stress induction than the
SAD  CA group. This is consistent with previous studies on the
impact of early adverse experiences on HPA-axis reactivity,
showing that changes in HPA-axis reactivity occur independent
of other neurobiological changes (Elzinga et al., 2008) and
independent of the emotional appraisal of the stress context
(Heim et al., 2000; Elzinga et al., 2008).
To the best of our knowledge, this is the ﬁrst study showing that
CA is associated with increased cortisol reactivity in SAD. These
ﬁndings are remarkably consistent with studies in MDD, where
HPA-axis hyperreactivity was also found in individuals with a
history of CA (Heim et al., 2000, 2002). Moreover, the increased
cortisol reactivity was not driven by the more severe depression
scores in this group, since the effects of abuse remained unchanged
and signiﬁcant when controlling for depression severity. The
enhanced cortisol reactivity in the SAD + CA group was neither
explained by social anxiety severity. It should be noted that the
assessment of childhood abuse was based on subjective reports
and therefore we cannot exclude the possibility that those SAD
patients with high cortisol reactivity might recollect more child-
hood abuse (rather than differ in the number or experience of
childhood abuse). However, thinking along these lines one would
expect inﬂated subjective reports on other measures as well (e.g.,
subjective anxiety ratings), but this was not the case. Moreover,
previous studies in healthy subjects found exactly the opposite
pattern that increased cortisol levels were associated with low
reports of abuse (see Elzinga et al., 2008; Carpenter et al., 2007),
suggesting that there is at least not a general pattern that enhanced
cortisol reactivity is associated with an inﬂated recollection of
traumatic events.
Taken together with the studies in patients with MDD, these
studies support the notion derived from animal research that
chronic stress during childhood is associated with a persistent
sensitization of the HPA-axis to stress (Heim and Nemeroff, 2001;
Kaufman et al., 2000; Sanchez, 2006). Moreover, the enhanced
cortisol reactivity in SAD patients reported earlier (see Roelofs
et al., 2009) was completely driven by the SAD patients with a
history of CA, as the SAD patients without CA did not differ from
healthy controls, despite very high anxiety levels during the TSST.
This suggests that the impact of CA on HPA-axis reactivity may
partly explain the mixed ﬁndings in previous SAD studies on
cortisol reactivity (see Condren et al., 2002; Furlan et al., 2001;
Levin et al., 1993; Martel et al., 1999).
Interestingly, PTSD patients did not show enhanced cortisol
reactivity to the TSST. At ﬁrst sight, this seems to suggest that CA
differentially affected the HPA-axis in PTSD vs SAD. It should be
noted, however, that several factorsmight have played a role in the
differences in cortisol levels between the SAD + CA and PTSD
patients. First, the types and severity of abuse reported by SAD and
PTSD patients were different, with PTSD patients reporting more
frequent and more severe physical and sexual abuse. In SAD,
emotional abuse was most prevalent and most severe, in line with
studies showing that emotional abuse and neglect particularly
predispose individuals for the development of SAD (Gibb et al.,
2007). Moreover, a relatively large number of PTSD patients (n = 7)
took oral contraceptives (in contrast to two participants in the
SAD + CA and two participants in the SAD  CA group), which
might have blunted cortisol reactivity in the PTSD group (see
Kirschbaum et al., 1999; Kudielka and Kirschbaum, 2005). Finally,
also the type of stressor might have played an important role. A
core feature of SAD is a fear of social situations in which a person
may be embarrassed or humiliated, which bears close resemblance
to the TSST. Thus, whereas the TSST is a speciﬁc symptom
provoking context for SAD patients, this is not the case for PTSD
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patients. This may explain the absence of increased cortisol
reactivity in PTSD patients in the present study, whereas in a
previous study in which PTSD patients were exposed to
personalized trauma scripts, PTSD patients did show elevated
cortisol levels (see Elzinga et al., 2003). In sum, a number of factors,
including type of trauma, type of stressor (i.e., trauma-related or
not), use of medication including oral contraceptives, but also
gender distribution, may all effect HPA-axis reactivity, making it
difﬁcult to draw ﬁnal conclusions on the status of HPA-axis
reactivity in PTSD (see also De Kloet et al., 2006).
In combination with recent ﬁndings that emotional abuse and
neglect is an important etiological factor in SAD (Gibb et al., 2007),
the present results suggest that one of the pathways from abuse to
the development of SAD (and MDD) might be associated with
enhanced cortisol reactivity to stress. We acknowledge that the
results are based on a small number of patients, and therefore
inferences should be made with caution. However, if replicated in
larger samples, these ﬁndings lead to the intriguing possibility that
childhood abusemight be associatedwith resilience, as indexed by
reduced cortisol reactivity (see Elzinga et al., 2008; Carpenter et al.,
2007) in those who emerge from the abuse without a disorder, but
vulnerability, as indexed by enhanced cortisol reactivity, in those
who emerge from the abuse with a psychiatric disorder, such as
SAD, MDD (Heim et al., 2001), and perhaps PTSD (Elzinga et al.,
2003; Bremner et al., 2003). In the context of prevention, it is
important to identify factors thatmight predict whowill emerge as
resilient and will be at risk to develop an affective disorder as a
result of early abuse. One step forward in predicting risk would be
to combine data on HPA-axis sensitization with genetics. It has
been shown that genetic factors (e.g., the serotonin transporter
gene 5-HTTLPR, and FKBP5 which is associated with GR respon-
siveness) may in part determine who is at risk to develop
psychopathology after being exposed to childhood abuse (see
Caspi et al., 2003; Kendler et al., 2005; Binder et al., 2008).
Interestingly, some of these same genes also appear to be
associated with alterations in HPA-axis reactivity after stress
exposure (Binder et al., 2008; McCormack et al., 2009; see also
Ouellet-Morin et al., 2008). When investigated in combination
with other risk and protective factors (i.e., social support, and
exposure to adult negative and positive life events), gen-
e  environment studies on HPA-axis reactivity might help to
identify the more vulnerable vs resilient individuals in the face of
early life stress.
Finally, if enhanced cortisol reactivity is indeed characteristic
of SAD patients with a history of abuse, this may also potentially
open interesting new venues for exploring the reversibility of this
stress sensitization. On the one hand, it will be interesting to
investigate the efﬁcacy of pharmacological interventions directly
aimed at reducing cortisol levels (i.e., MR or GR antagonists). On
the other hand, a study in chronically depressed patients has
shown that among depressed patients with a history of early
childhood trauma psychotherapy was superior in reducing
depressive symptoms compared to antidepressant monotherapy.
Along these lines, one would expect that psychotherapy is also an
essential element in the treatment of SAD patients with a history
of early abuse. Taken together, this study should be considered as
a ﬁrst step in understanding the impact of CA on HPA-axis
sensitization in SAD, which, if replicated in larger samples, may
have important implications for the prevention and treatment
of SAD.
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